Biodegradable magnesium implants: a potential scaffold for bone tumor patients

36Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Relapse and metastasis of tumor may occur for osteosarcoma (OS) patients after clinical resection. Conventional metallic scaffolds provide sufficient mechanical support to the defected bone but fail to eradicate recurring tumors. Here we report that biodegradable magnesium (Mg) wire-based implant can inhibit OS growth. In brief, the Mg wires release Mg ions to activate the transport of zinc finger protein Snail1 from cytoplasm to cell nucleus, which induces apoptosis and inhibits proliferation of OS cells through a parallel antitumor signaling pathway of miRNA-181d-5p/TIMP3 and miRNA-181c-5p/NLK downstream. Simultaneously, the hydrogen gas evolution from Mg wires eliminates intracellular excessive reactive oxygen species, by which the growth of bone tumor cells is suppressed. The subcutaneous tumor-bearing experiment of OS cells in nude mice further confirms that Mg wires can effectively inhibit the growth of tumors and prolong the survival of tumor-bearing mice. In addition, Mg wires have no toxicity to normal cells and tissues. These results suggest that Mg implant is a potential anti-tumor scaffold for OS patients.

Cite

CITATION STYLE

APA

Zan, R., Ji, W., Qiao, S., Wu, H., Wang, W., Ji, T., … Zhang, X. (2021). Biodegradable magnesium implants: a potential scaffold for bone tumor patients. Science China Materials, 64(4), 1007–1020. https://doi.org/10.1007/s40843-020-1509-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free